$KWR

QUAKER CHEMICAL CORP

CIK:0000081362|SEC Filings

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 532,550	$ 483,400	$ 1,013,029	$ 926,314
Cost of goods sold (excluding amortization expense - See Note 13)	343,346	311,677	647,090	593,331
Gross profit	189,204	171,723	365,939	332,983
Selling, general and administrative expenses	140,485	126,600	276,250	245,646
Impairment charges	0	88,840	0	88,840
Restructuring and related charges, net	8,116	8,793	15,497	23,383
Operating income (loss)	40,603	(52,510)	74,192	(24,886)
Other income (expense), net	406	(653)	383	(1,362)
Interest expense	(9,873)	(12,779)	(19,752)	(22,324)
Income (loss) before taxes and equity in net income of associated companies	31,136	(65,942)	54,823	(48,572)
Taxes on income before equity in net income of associated companies	11,172	5,472	18,317	13,014
Income (loss) before equity in net income of associated companies	19,964	(71,414)	36,506	(61,586)
Equity in net income of associated companies	6,849	4,851	10,049	7,940
Net income (loss)	26,813	(66,563)	46,555	(53,646)
Less: Net (loss) income attributable to noncontrolling interest	(22)	17	51	12
Net income (loss) attributable to Quaker Chemical Corporation	$ 26,835	$ (66,580)	$ 46,504	$ (53,658)
Per share data:
Net income attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share)	$ 1.56	$ (3.78)	$ 2.69	$ (3.04)
Net income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share)	1.55	(3.78)	2.68	(3.04)
Dividends declared (in dollars per share)	$ 0.508	$ 0.485	$ 1.016	$ 0.970

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		9 Months Ended	12 Months Ended
	Jun. 30, 2026	Mar. 31, 2026	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2026	Jun. 30, 2025	Sep. 30, 2025	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities
Net income (loss)	$ 26,813	$ 19,742	$ (66,563)	$ 12,917	$ 46,555	$ (53,646)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation and amortization					51,011	44,278
Equity in undistributed earnings of associated companies, net of dividends					(3,596)	(44)
Deferred income taxes					(11,730)	(15,634)
Share-based compensation					6,888	6,903
Impairment charges	0		88,840		0	88,840
Restructuring and related charges, net	8,116		8,793		15,497	23,383
Inventory step-up amortization					0	6,022
Loss (gain) on disposal of property, plant and equipment and other assets					121	(2,108)
Other adjustments					(1,877)	(5,228)
Increase (decrease) in cash from changes in current assets and current liabilities, net of acquisitions:
Accounts receivable					(47,628)	3,022
Inventories					(40,685)	(11,826)
Prepaid expenses and other current assets					(10,450)	(3,943)
Accrued restructuring					(11,340)	(15,946)
Accounts payable and accrued liabilities					40,476	(25,551)
Net cash provided by operating activities					33,242	38,522
Cash flows from investing activities
Investments in property, plant and equipment					(21,018)	(20,289)
Payments related to acquisitions, net of cash acquired					0	(164,078)
Proceeds from disposition of assets					0	2,950
Other investing activities					2,249	697
Net cash used in investing activities					(18,769)	(180,720)
Cash flows from financing activities
Payments of long-term debt					(629,685)	(17,205)
Proceeds from long-term debt					800,000	0
Borrowings on revolving credit facilities		51,053			197,307	283,000	$ 328,201	$ 382,299	$ 347,763
Payments on revolving credit facilities		(37,000)			(356,305)	(67,000)	(159,263)	(208,057)	(329,847)
Payments on other debt					0	(101)
Financing-related debt issuance costs					(6,232)	0
Dividends paid					(17,627)	(17,146)
Shares purchased under share repurchase programs					(24,181)	(32,693)
Other stock related activity					(1,755)	(1,301)
Net cash (used in) provided by financing activities					(38,478)	147,554
Effect of foreign exchange rate changes on cash					(731)	7,682
Net (decrease) increase in cash and cash equivalents					(24,736)	13,038
Cash and cash equivalents at the beginning of the period		$ 179,829		$ 188,880	179,829	188,880	$ 188,880	188,880
Cash and cash equivalents at the end of the period	$ 155,093		$ 201,918		155,093	201,918		$ 179,829	$ 188,880
Non-cash activities:
Accrued purchases of property, plant and equipment, net					$ 10,963	$ 7,263

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 155,093	$ 179,829
Accounts receivable, net	463,603	417,157
Inventories
Raw materials and supplies	142,116	124,751
Work-in-process and finished goods	161,994	141,025
Prepaid expenses and other current assets	68,242	58,428
Total current assets	991,048	921,190
Property, plant and equipment, at cost	624,164	604,787
Less: Accumulated depreciation	(309,568)	(291,364)
Property, plant and equipment, net	314,596	313,423
Right-of-use lease assets	53,650	38,737
Goodwill	503,721	501,720
Other intangible assets, net	829,479	873,540
Investments in associated companies	105,906	106,915
Deferred tax assets	12,737	12,128
Other non-current assets	39,979	30,283
Total assets	2,851,116	2,797,936
Current liabilities
Short-term borrowings and current portion of long-term debt	15,654	35,657
Accounts payable	234,319	198,929
Dividends payable	8,744	8,804
Accrued compensation	41,280	41,192
Accrued restructuring	8,807	8,351
Accrued pension and postretirement benefits	2,120	2,126
Other accrued liabilities	92,473	85,097
Total current liabilities	403,397	380,156
Long-term debt	857,790	834,901
Long-term lease liabilities	37,628	22,759
Deferred tax liabilities	131,314	140,814
Non-current accrued pension and postretirement benefits	20,159	20,615
Other non-current liabilities	20,229	22,192
Total liabilities	1,470,517	1,421,437
Commitments and contingencies (Note 18)
Equity
Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding June 30, 2026 – 17,212,963 shares; December 31, 2025 – 17,331,779 shares	17,213	17,332
Capital in excess of par value	855,896	874,826
Retained earnings	625,554	596,616
Accumulated other comprehensive loss	(121,488)	(115,661)
Total Quaker shareholders’ equity	1,377,175	1,373,113
Noncontrolling interest	3,424	3,386
Total equity	1,380,599	1,376,499
Total liabilities and equity	$ 2,851,116	$ 2,797,936